Generics maker Perrigo has reported that its corporate offices were searched by the agents of the US Department of Justice (DOJ) antitrust division as part of an ongoing investigation related to drug pricing in the pharmaceutical industry.

The company did not disclose details about the search, nor specified on which offices the search warrants were executed.

Perrigo’s corporate headquarters is located in Dublin, Ireland, and its North American base of operations is situated in Allegan, Michigan, US.

In a statement, Perrigo said: “As has been previously disclosed by a number of companies, the antitrust division has been looking at industry-wide pricing practices. The company is taking this investigation seriously and is cooperating with the appropriate authorities.”

"The company is taking this investigation seriously and is cooperating with the appropriate authorities."

According to a document filed in the court last February, the government is looking at the prices of skin drugs manufactured by Perrigo and other companies, reported Bloomberg.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

See Also:

The antitrust division is also currently investigating multiple pharmaceutical companies over pricing practices, bid rigging and other anti-competitive conducts, reported Genetic Engineering & Biotechnology News.

Some of the companies being investigated include Mylan, Endo International, Lannett and Teva Pharmaceutical Industries.

Commenting on the Perrigo search, RBC Capital Markets analyst Randall Stanicky was quoted by Bloomberg as saying: “This is going to bring the DOJ generic pricing risk back into focus.”

Perrigo manufactures over-the-counter healthcare products, supplies infant formulas and produces extended topical prescription drugs.